{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:18:16Z","timestamp":1787811496977,"version":"build-2784847793"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Malignant spindle cell tumors arising in patients with neurofibromatosis are diagnostically challenging because malignant peripheral nerve sheath tumor (MPNST) and emerging NTRK-rearranged mesenchymal neoplasms may show overlapping clinical, histological, and immunophenotypic features. We report a 31-year-old man with a more than 20-year history of neurofibromatosis who presented with progressive lumbosacral pain and left lower-limb numbness. Imaging revealed a large cystic-solid sacral mass involving the S1\u2013S2 region and extending through the sacral foramina into the pelvis. Core needle biopsy showed an intermediate-grade malignant spindle cell tumor with partial CD34 expression, strong pan-TRK positivity, increased p53 expression, and a Ki-67 labeling index up to 50% in hotspot areas. NTRK1 break-apart fluorescence\n                    <jats:italic>in situ<\/jats:italic>\n                    hybridization (FISH) was negative; however, RNA-based next-generation sequencing identified an RBPMS::NTRK3 fusion, establishing a molecularly confirmed NTRK3-rearranged spindle cell neoplasm and explaining the pan-TRK positivity as a true-positive result. The negative NTRK1 FISH reflected involvement of NTRK3 rather than NTRK1, illustrating that single-gene FISH cannot exclude an NTRK fusion. Given the large local tumor burden, neurological symptoms, high surgical morbidity, and the confirmed actionable fusion, the patient received molecularly guided entrectinib combined with palliative radiotherapy, with marked pain relief, neurological improvement, and radiological tumor shrinkage; at the most recent follow-up, approximately 7 months after starting entrectinib, he remained without evidence of disease progression. This case underscores that pan-TRK positivity should prompt confirmatory RNA-based sequencing rather than reliance on single-gene FISH; that actionable NTRK fusions may occur in the neurofibromatosis setting, where MPNST is the principal differential; and that molecularly informed multimodal therapy can benefit anatomically complex tumors, although response attribution requires caution when targeted therapy and radiotherapy are combined.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1914327","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:34:26Z","timestamp":1787808866000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RBPMS::NTRK3-rearranged sacral malignant spindle cell tumor in neurofibromatosis diagnosed by RNA sequencing: a case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Chaopeng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujiang","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaowen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Central Hospital of Guangdong Provincial Nongken","place":["Zhanjiang, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/cancers15041077","article-title":"Malignant peripheral nerve sheath tumors: latest concepts in disease pathogenesis and clinical management","volume":"15","author":"Yao","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11912-009-0045-z","article-title":"Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"11","author":"Widemann","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/children9010038","article-title":"Malignant peripheral nerve sheath tumors\u2014a comprehensive review of pathophysiology, diagnosis, and multidisciplinary management","volume":"9","author":"Knight","year":"2022","journal-title":"Children (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.anndiagpath.2013.10.007","article-title":"Malignant peripheral nerve sheath tumor: pathology and genetics","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"B6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41379-020-00657-x","article-title":"Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions","volume":"34","author":"Br\u010di\u0107","year":"2021","journal-title":"Mod Pathol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/annonc\/mdz204","article-title":"ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research","volume":"30","author":"Marchi\u00f2","year":"2019","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.pathol.2022.10.003","article-title":"NTRK-rearranged spindle cell neoplasms: a clinicopathological and molecular study of 13 cases with peculiar characteristics at one of the largest institutions in China","volume":"55","author":"Yin","year":"2023","journal-title":"Pathology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41379-021-01005-3","article-title":"Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements","volume":"35","author":"Tsai","year":"2022","journal-title":"Mod Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1308916","DOI":"10.3389\/fonc.2024.1308916","article-title":"Case report: adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic","volume":"14","author":"Cao","year":"2024","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e2200528","DOI":"10.1200\/PO.22.00528","article-title":"Marked response to larotrectinib in pelvic spindle cell sarcoma with concurrent TPM3-NTRK1 fusion and CDK4\/MDM2 amplification: a case report","volume":"7","author":"Huang","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00432-024-06042-4","article-title":"NTRK-rearranged spindle cell tumor with SPECC1L-NTRK3 fusion in the thoracic spine: a case report","volume":"151","author":"Zhou","year":"2025","journal-title":"J Cancer Res Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00401-022-02515-3","article-title":"NTRK rearrangements in a subset of NF1-related malignant peripheral nerve sheath tumors as novel actionable target","volume":"145","author":"Hiemcke-Jiwa","year":"2023","journal-title":"Acta Neuropathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/jcp-2025-210513","article-title":"Evaluation of pan-TRK immunostaining in malignant peripheral nerve sheath tumours: does its positivity indicate NTRK rearrangements or neural differentiation?","volume":"79","author":"Mori","year":"2026","journal-title":"J Clin Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/PAS.0000000000000655","article-title":"Malignant peripheral nerve sheath tumor is a challenging diagnosis","volume":"40","author":"Le Guellec","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"i40","DOI":"10.1093\/noajnl\/vdz047","article-title":"Diagnosis and management of malignant peripheral nerve sheath tumors: current practice and future perspectives","volume":"2","author":"Prudner","year":"2020","journal-title":"Neurooncol Adv"},{"key":"B19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.pathol.2020.02.004","article-title":"NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm","volume":"52","author":"Wong","year":"2020","journal-title":"Pathology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/gcc.22877","article-title":"Soft tissue tumors characterized by a wide spectrum of kinase fusions share a lipofibromatosis-like neural tumor pattern","volume":"59","author":"Kao","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41379-021-00913-8","article-title":"NTRK insights: best practices for pathologists","volume":"35","author":"Hechtman","year":"2022","journal-title":"Mod Pathol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1914327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:34:28Z","timestamp":1787808868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1914327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":23,"alternative-id":["10.3389\/fmed.2026.1914327"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1914327","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1914327"}}